{"DataElement":{"publicId":"6670501","version":"1","preferredName":"Female Genital Grading Table Assessment Category","preferredDefinition":"The category used in the table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies.","longName":"FGGT_CAT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"6650909","version":"1","preferredName":"Female Genital Grading Table Assessment","preferredDefinition":"A table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies._The final result of a determination of the value, significance, or extent of.","longName":"6650907v1.0:2465182v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"6650907","version":"1","preferredName":"Female Genital Grading Table","preferredDefinition":"A table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies.","longName":"C157688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Female Genital Grading Table","conceptCode":"C157688","definition":"A table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8254C51F-F4C2-6114-E053-F662850A1194","latestVersionIndicator":"Yes","beginDate":"2019-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-02-20","modifiedBy":"ONEDATA","dateModified":"2019-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8254C51F-F4D0-6114-E053-F662850A1194","latestVersionIndicator":"Yes","beginDate":"2019-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-02-20","modifiedBy":"ZHANGWE","dateModified":"2019-03-12","changeDescription":"1/20/2019 created for DCP SVAR UWI2017-09-01#SVAR02132019, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6670495","version":"1","preferredName":"Female Genital Grading Table Category","preferredDefinition":"A table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies._A grouping of items based on some commonality or by user defined characteristics.","longName":"6670495v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Uterine Bleeding and Pregnancy Complications","valueDescription":"Uterus Hemorrhage And Pregnancy Complication","ValueMeaning":{"publicId":"6670496","version":"1","preferredName":"Uterus Hemorrhage And Pregnancy Complication","longName":"6670496","preferredDefinition":"A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.: The flow of blood from a ruptured blood vessel.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterus","conceptCode":"C12405","definition":"A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pregnancy Complication","conceptCode":"C34941","definition":"The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B0F8-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7DBE2-B111-65AA-E053-F662850AA6F2","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"},{"value":"Infections and Dysplasia","valueDescription":"Infection And Dysplasia","ValueMeaning":{"publicId":"6670497","version":"1","preferredName":"Infection And Dysplasia","longName":"6670497","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dysplasia","conceptCode":"C4086","definition":"A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B11F-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7DBE2-B138-65AA-E053-F662850AA6F2","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"},{"value":"Composite Signs/Symptoms","valueDescription":"Composite Sign Symptom","ValueMeaning":{"publicId":"6670498","version":"1","preferredName":"Composite Sign Symptom","longName":"6670498","preferredDefinition":"Consisting of separate interconnected parts.: Objective evidence of disease perceptible to the examining healthcare provider.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Composite","conceptCode":"C61520","definition":"Consisting of separate interconnected parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign","conceptCode":"C53458","definition":"Objective evidence of disease perceptible to the examining healthcare provider.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B146-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7DBE2-B15F-65AA-E053-F662850AA6F2","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"},{"value":"Individual Signs/Symptoms","valueDescription":"Individual Sign Symptom","ValueMeaning":{"publicId":"6670499","version":"1","preferredName":"Individual Sign Symptom","longName":"6670499","preferredDefinition":"Individual; a single human being.: Objective evidence of disease perceptible to the examining healthcare provider.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Individual","conceptCode":"C17719","definition":"Individual; a single human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign","conceptCode":"C53458","definition":"Objective evidence of disease perceptible to the examining healthcare provider.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B16D-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7DBE2-B186-65AA-E053-F662850AA6F2","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6670494","version":"1","preferredName":"Female Genital Grading Table Category","preferredDefinition":"A table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C157688:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Female Genital Grading Table","conceptCode":"C157688","definition":"A table within the standard terminology developed by the NIH Division of AIDS (DAIDS) to report expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies. This table contains specific adverse event grading terminology for Female Genital Microbicide Studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B0CB-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B0DC-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"MAESKEB","dateModified":"2020-09-22","changeDescription":"3/12/2019 created for DCP SVAR UWI2017-09-01#SVAR02132019, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"FGGT Category","type":"Preferred Question Text","description":"FGGT Category","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E7DBE2-B191-65AA-E053-F662850AA6F2","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-03-12","modifiedBy":"MAESKEB","dateModified":"2020-09-22","changeDescription":"3/12/2019 created for DCP SVAR UWI2017-09-01#SVAR02132019,wz","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}